Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sofpironium Bromide
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Fresh Tracks Therapeutics
Deal Size : $3.5 million
Deal Type : Licensing Agreement
Brickell Biotech Announces Settlement of Dispute with Bodor Labs
Details : The settlement resolves the previously disclosed dispute related to the sofpironium bromide license agreement allowing the Company to continue to produce sofpironium bromide to treat hyperhidrosis.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : $1.0 million
February 18, 2020
Lead Product(s) : Sofpironium Bromide
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Fresh Tracks Therapeutics
Deal Size : $3.5 million
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?